Phase Forward to Participate in October Industry Events
October 01 2009 - 9:00AM
Business Wire
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, will
participate at three upcoming industry events in October including
the 3rd Annual DIA Clinical Forum. Details are as follows:
At the 3rd Annual DIA Clinical Forum, October 19-21, in Nice,
France, Phase Forward will share insights in four sessions:
Who: Andrea Bradbury, Vice
President, Compliance and Quality, Phase Forward Clarix Products
Group (Panelist)What: “A QA Perspective on XP in a Regulated
Industry”When: Monday, October 19, 2:00-3:30 p.m. local
time
Who: Joerg Dillert, Principal
Consultant, Phase Forward (Panelist)What: “HL7 RIM – An
Introduction for Non-technical Professionals”When: Tuesday,
October 20, 4:00-5:30 p.m. local time
Who: Wayne Kubick, Vice President
and Chief Quality Officer, Phase Forward Lincoln Safety Group
(Panelist)What: “The Future of Clinical Data: The Evolving
Impact of CDISC and HL7 on Data Management, Submission, and
Pharmacovigilance”When: Tuesday, October 20, 4:00-5:30 p.m.
local time
Who: William DuMouchel, Chief
Statistical Scientist, Phase Forward Lincoln Safety Group
(Panelist)What: “Safety Signal Detection in Longitudinal
Observational Data”When: Wednesday, October 21, 11:00
a.m.-12:30 p.m. local time
Additionally, at the 2009 SCDM Annual Conference, October 4-6,
in Seattle, WA, Phase Forward will exhibit its full solution set at
booth # 208. Phase Forward will also exhibit its clinical data
analysis and reporting automation and compliance technologies at
booth # 17 at the PhuSE 2009 Conference, October 19-21, in Basel,
Switzerland.
Members of the media interested in speaking with Phase Forward
at the DIA Clinical Forum and/or the PHuSE Conference should
contact Maria Sumner at +44 1628 640743 or
maria.sumner@phaseforward.com, and for the SCDM Conference, Meghan
Locke at 781-672-3147 or mlocke@chenpr.com.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 290 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2024 to Aug 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Aug 2023 to Aug 2024